•
Dec 31, 2016

Cocrystal Pharma Q4 2016 Earnings Report

EPS
-$3.06
Previous year: -$0.05
+6020.0%
Cash and Equivalents
$3.61M
Previous year: $9.28M
-61.1%
Free Cash Flow
-$2.3M
Previous year: -$3.16M
-27.2%
Total Assets
$125M
Previous year: $224M
-44.3%

Cocrystal Pharma

Cocrystal Pharma